Elena Prado-Mel

5PUBLICATIONS
18CO-AUTHORS
Nutrigenomics and personalised nutritionAboriginal and Torres Strait Islander genomicsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 13, 2026
Diagnostic Performance and Agreement of MST and NUTRISCORE Compared with GLIM Criteria in Ambulatory Cancer Patients: Results from the OncoNutridos Study.

|Jan 28, 2026
Impact of UGT1A1*28 Allele on the Safety and Effectiveness of Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer: Real-World Evidence.

Fernando do Pazo-Oubiña, Betel Del Rosario García, Marta Miarons

|Sep 12, 2024
Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study.

Isabel María Carrión-Madroñal, Rocío Díaz-Acedo, Santiago José Lora-Escobar

|Feb 25, 2023
Impact of Frailty on Outcomes of First-Line Pembrolizumab Monotherapy in a Real-World Population with Advanced Non-Small Cell Lung Cancer.

Rocío Jiménez Galán, Elena Prado-Mel, Maria Alvarez de Sotomayor

|Sep 28, 2021
Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population.

Rocío Jiménez Galán, Elena Prado-Mel, María Antonia Pérez-Moreno

Pageof 1

Frequent Collaborators

1 joint publications

Olatz Olariaga

1 joint publications

Mariola Sirvent

1 joint publications

Rosa Romero-Jimenez

1 joint publications

Maria Encina García